Search alternatives:
lbar » bar (Expand Search), luar (Expand Search), mbar (Expand Search)
libat » liat (Expand Search), lihat (Expand Search)
hebat » heat (Expand Search)
clobar » cobar (Expand Search), clebar (Expand Search), ccobar (Expand Search), clohar (Expand Search)
tamar » tamara (Expand Search), itamar (Expand Search), taman (Expand Search)
lobar » lebar (Expand Search), cobar (Expand Search), lohar (Expand Search)
lbar » bar (Expand Search), luar (Expand Search), mbar (Expand Search)
libat » liat (Expand Search), lihat (Expand Search)
hebat » heat (Expand Search)
clobar » cobar (Expand Search), clebar (Expand Search), ccobar (Expand Search), clohar (Expand Search)
tamar » tamara (Expand Search), itamar (Expand Search), taman (Expand Search)
lobar » lebar (Expand Search), cobar (Expand Search), lohar (Expand Search)
-
141
-
142
-
143
Postcoital bleeding in a 26-year-old woman: a rare case of a cervical capillary haemangioma
Published 2025Journal article -
144
Molecular profiling of peripheral immune cell subsets in patients with rheumatoid arthritis
Published 2020Conference item -
145
-
146
-
147
-
148
Effect of solvent segregation on the performance of lithium-ion batteries
Published 2023Conference item -
149
Strategy for measuring thermodynamic factors in lithium electrolytes with two neutral solvents
Published 2021Conference item -
150
-
151
-
152
-
153
Regulation with borders?—‘nature’ and ‘society’ in marine protection areas
Published 2024Journal article -
154
Justifying harm-based strict liability: reflections on Keating’s Reasonableness and Risk
Published 2024Journal article -
155
Competence, competition, content and control: sociological perspectives on educational assessment
Published 2025Journal article -
156
-
157
Making a martyr: Demosthenes and Euphraeus of Oreus (Third Philippic 59-62)
Published 2024Journal article -
158
Electrospun fibres with hyaluronic acid-chitosan nanoparticles produced by a portable device
Published 2022Conference item -
159
-
160
Autoimmune encephalitis: should we consider third-line immunotherapies earlier?
Published 2023Journal article